Dennis R. Benjamin

3.8k total citations
41 papers, 2.3k citations indexed

About

Dennis R. Benjamin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Dennis R. Benjamin has authored 41 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Molecular Biology. Recurrent topics in Dennis R. Benjamin's work include Monoclonal and Polyclonal Antibodies Research (21 papers), HER2/EGFR in Cancer Research (18 papers) and Multiple Myeloma Research and Treatments (7 papers). Dennis R. Benjamin is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), HER2/EGFR in Cancer Research (18 papers) and Multiple Myeloma Research and Treatments (7 papers). Dennis R. Benjamin collaborates with scholars based in United States, United Kingdom and Austria. Dennis R. Benjamin's co-authors include Nicole M. Okeley, Peter D. Senter, Stephen C. Alley, Russell J. Sanderson, Xinqun Zhang, Chris P. Ponting, Scott C. Jeffrey, Jamie B. Miyamoto, Che‐Leung Law and Damon L. Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Dennis R. Benjamin

40 papers receiving 2.2k citations

Peers

Dennis R. Benjamin
Ola M. Saad United States
Stephen C. Alley United States
Katherine R. Kozak United States
Roger F. Zabinski United States
Paul J. Yazaki United States
Leslie A. Khawli United States
Robert P. Lyon United States
Bruno Catimel Australia
Roxana E. Iacob United States
James C. Marsters United States
Ola M. Saad United States
Dennis R. Benjamin
Citations per year, relative to Dennis R. Benjamin Dennis R. Benjamin (= 1×) peers Ola M. Saad

Countries citing papers authored by Dennis R. Benjamin

Since Specialization
Citations

This map shows the geographic impact of Dennis R. Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis R. Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis R. Benjamin more than expected).

Fields of papers citing papers by Dennis R. Benjamin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis R. Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis R. Benjamin. The network helps show where Dennis R. Benjamin may publish in the future.

Co-authorship network of co-authors of Dennis R. Benjamin

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis R. Benjamin. A scholar is included among the top collaborators of Dennis R. Benjamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis R. Benjamin. Dennis R. Benjamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Fu, Michelle Ulrich, Vincent Feng-Sheng Shih, et al.. (2019). Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody–Drug Conjugate Via Fc–FcγR Interaction. Molecular Cancer Therapeutics. 18(4). 780–787. 37 indexed citations
2.
Li, Fu, Michelle Ulrich, Mechthild Jonas, et al.. (2017). Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 16(7). 1347–1354. 53 indexed citations
3.
Fu, Li, Kim K. Emmerton, Mechthild Jonas, et al.. (2016). Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models. Cancer Research. 76(9). 2710–2719. 231 indexed citations
4.
Fu, Li, Michelle Ulrich, Mechthild Jonas, et al.. (2016). Abstract 1285: Tumor associated macrophages can process antibody-drug conjugates and contribute to antitumor activity in preclinical xenograft models. Cancer Research. 76(14_Supplement). 1285–1285. 2 indexed citations
5.
Belcher, John D., Chunsheng Chen, Julia Nguyen, et al.. (2015). The Fucosylation Inhibitor, 2-Fluorofucose, Inhibits Vaso-Occlusion, Leukocyte-Endothelium Interactions and NF-ĸB Activation in Transgenic Sickle Mice. PLoS ONE. 10(2). e0117772–e0117772. 28 indexed citations
6.
Ryan, Maureen C., Brian Schimpf, Martha E. Anderson, et al.. (2015). SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies. Blood. 126(23). 594–594. 4 indexed citations
7.
Sussman, Django, Leia M. Smith, Martha E. Anderson, et al.. (2014). SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer. Molecular Cancer Therapeutics. 13(12). 2991–3000. 104 indexed citations
8.
Fu, Li, Xinqun Zhang, Kim K. Emmerton, et al.. (2014). Abstract 3694: Relationship between in vivo antitumor activity of ADC and payload release in preclinical models. Cancer Research. 74(19_Supplement). 3694–3694. 7 indexed citations
9.
Arico-Muendel, Christopher C., Bruce Belanger, Dennis R. Benjamin, et al.. (2013). Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity. Drug Metabolism and Disposition. 41(4). 814–826. 9 indexed citations
10.
Arico-Muendel, Christopher C., Dennis R. Benjamin, Paolo A. Centrella, et al.. (2013). Orally Active Fumagillin Analogues: Transformations of a Reactive Warhead in the Gastric Environment. ACS Medicinal Chemistry Letters. 4(4). 381–386. 7 indexed citations
11.
Okeley, Nicole M., Stephen C. Alley, Martha E. Anderson, et al.. (2013). Development of orally active inhibitors of protein and cellular fucosylation. Proceedings of the National Academy of Sciences. 110(14). 5404–5409. 147 indexed citations
12.
Sutherland, May S.K., Roland B. Walter, Scott C. Jeffrey, et al.. (2013). SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood. 122(8). 1455–1463. 291 indexed citations
13.
Sutherland, May S.K., Roland B. Walter, Scott C. Jeffrey, et al.. (2012). SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML. Blood. 120(21). 3589–3589. 7 indexed citations
14.
Okeley, Nicole M., Jamie B. Miyamoto, Xinqun Zhang, et al.. (2010). Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate. Clinical Cancer Research. 16(3). 888–897. 291 indexed citations
15.
Zhang, Xinqun, Nicole M. Okeley, Jocelyn R. Setter, et al.. (2010). Abstract 5334: Mechanism of cysteine-mcMMAF release from the stably linked antibody-drug conjugate SGN-75. Cancer Research. 70(8_Supplement). 5334–5334. 1 indexed citations
16.
Alley, Stephen C., Xinqun Zhang, Nicole M. Okeley, et al.. (2009). The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity. Journal of Pharmacology and Experimental Therapeutics. 330(3). 932–938. 100 indexed citations
17.
Alley, Stephen C., Nicole M. Okeley, Russell J. Sanderson, et al.. (2006). Intracellular metabolism of antibody-drug conjugates: identification and quantitation of released drugs. Cancer Research. 66. 469–469. 3 indexed citations
18.
Bouchard, Mario, Dennis R. Benjamin, Paula Tito, Carol V. Robinson, & Christopher M. Dobson. (2000). Solvent Effects on the Conformation of the Transmembrane Peptide Gramicidin A: Insights from Electrospray Ionization Mass Spectrometry. Biophysical Journal. 78(2). 1010–1017. 25 indexed citations
19.
Ponting, Chris P. & Dennis R. Benjamin. (1996). A novel family ofras-binding domains. Trends in Biochemical Sciences. 21(11). 422–425. 173 indexed citations
20.
Benjamin, Dennis R., David W. Markby, Henry R. Bourne, & Irwin D. Kuntz. (1995). Complete 1H, 13C, and 15N Assignments and Secondary Structure of the GTPase Activating Domain of Gs. Biochemistry. 34(1). 155–162. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ola M. Saad Breakdown of academic impact, for papers by Stephen C. Alley Breakdown of academic impact, for papers by Katherine R. Kozak Breakdown of academic impact, for papers by Roger F. Zabinski Breakdown of academic impact, for papers by Paul J. Yazaki Breakdown of academic impact, for papers by Leslie A. Khawli Breakdown of academic impact, for papers by Robert P. Lyon Breakdown of academic impact, for papers by Bruno Catimel Breakdown of academic impact, for papers by Roxana E. Iacob Breakdown of academic impact, for papers by James C. Marsters
Rankless by CCL
2026